Journals / Mucosa / 2022 / Cilt: 5 - Sayı: 2

Management of post-COVID olfactory disorder: is olfactory training effective on recovery of olfactory function?

COVID sonrası koku alma bozukluğunun yönetimi: Koku alma eğitimi koku alma fonksiyonunun iyileşmesi üzerinde etkili mi?

Journal
Mucosa
Pages
42–50
Publication Date
2022-09-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was observed that the olfactory threshold scores increased significantly after the olfactory training (P

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background The number of patients presenting with sudden onset and persistant anosmia and other olfactory disorders, which is a finding related to coronavirus disease has increased considerably.
📊
Key Findings & Data:Objective In this study, we aimed to evaluate the efficacy of olfactory training in patients with persistent anosmia after Covid-19 infection.
💡
Conclusion & Impact:It was observed that the olfactory threshold scores increased significantly after the olfactory training (P
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:anosmi · koku eşiği · koku alma bozukluğu

Abstract

Background The number of patients presenting with sudden onset and persistant anosmia and other olfactory disorders, which is a finding related to coronavirus disease has increased considerably. Objective In this study, we aimed to evaluate the efficacy of olfactory training in patients with persistent anosmia after Covid-19 infection. Methods Forty-six patients who applied for a sudden loss of smell after Covid-19 infection and still had olfactory disorders were included in the study. Odor threshold and odor identification tests were performed on the patients before the treatment. As olfactory training, four scent bottles included the following groups: phenyl ethyl alcohol, eucalyptol group, citronellal group and eugenol group were given to patients, and they were instructed to sniff the odors twice a day, for five seconds each, when they woke up in the morning and before they went to sleep and make a daily check that they applied the treatment. Patients who continued the training for 12 weeks were re-evaluated with the odor threshold test and odor identification test. Results The pre-training mean olfactory threshold score of the patients was 1.65±1.74, and the post-training mean olfactory threshold score was 3.89±2.73. It was observed that the olfactory threshold scores increased significantly after the olfactory training (P

Özet

Arka plan COVID-19 hastalığına bağlı ani başlangıçlı anosmi ve diğer koku alma bozuklukları ile başvuran hasta sayısı oldukça artmıştır. Amaç Bu çalışmada Covid-19 enfeksiyonu sonrası inatçı anosmisi olan hastalarda koku alma eğitiminin etkinliğini değerlendirmeyi amaçladık. Yöntem Çalışmaya COVID-19 enfeksiyonu sonrası ani koku kaybı şikayeti ile başvuran ve koku alma bozuklukları devam eden 46 hasta alındı. Tedavi öncesi hastalara koku eşiği ve koku tanımlama testleri yapıldı. Koku eğitimi olarak hastalara fenil etil alkol, okaliptol grubu, sitronelal grubu ve öjenol grubu olmak üzere 4 koku şişesi verilmiş ve hastalara sabah uyandıklarında kokuları günde iki kez 5’er saniye olmak üzere koklamaları söylenmiştir. Hastaların sabah ve yatmadan önce tedaviyi uyguladıkları günlük olarak kontrol edildi. Eğitime 12 hafta devam eden hastalar koku eşiği testi ve koku tanımlama testi ile yeniden değerlendirildi. Bulgular Hastaların eğitim öncesi ortalama koku eşik puanı 1.65±1.74, eğitim sonrası ortalama koku eşiği puanı 3.89±2.73 idi. Olfaktör eşik puanlarının olfaktör eğitimden sonra anlamlı olarak arttığı görüldü (P

🔖

Cite This Article

DEMİR, S., SİZER, B., SIRMA, E. (2022). Management of post-COVID olfactory disorder: is olfactory training effective on recovery of olfactory function?. Mucosa, Cilt: 5 - Sayı: 2, 42–50. https://ajindex.com/articles/839999

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. World Health Organization (WHO). Pneumonia of unknown cause China. Geneva: WHO 2020 (cited 2021 July 20).Available from: URL: https://www.who.int/csr/don/05-january-2020-pneumonia-ofunkowncause- china/ en/ Fu L, Wang B, Yuan T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J Infect 2020;80:656-65.
  2. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507-13. Elibol E. Otolaryngological symptoms in COVID-19. Eur Arch Otorhinolaryngol 2021;278:1233-6.
  3. Rocke J, Hopkins C, Philpott C, Kumar N. Is loss of sense of smell a diagnostic marker in COVID-19: a systematic review and meta-analysis. Clin Otolaryngol 2020;45:914-22.
  4. Hopkins C, Surda P, Kumar N. Presentation of new onset anosmia during the COVID-19 pandemic. Rhinology 2020;58:295-8.
  5. Russell B, Moss C, Rigg A, Hopkins C, Papa S, Van Hemelrijck M. Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say? Ecancermedicalscience 2020;14:ed98. Soler ZM, Patel ZM, Turner JH, Holbrook EH. A primer on viral-associated olfactory loss in the era of COVID-19. Int Forum Allergy Rhinol 2020;10:814-20.
  6. Hummel T, Whitcroft KL, Andrews P, et al. Position paper on olfactory dysfunction. Rhinology 2017;56:1-30.
  7. Vaira LA, Salzano G, Fois AG, Piombino P, De Riu G. Potential pathogenesis of ageusia and anosmia in COVID-19 patients. Int Forum Allergy Rhinol 2020;10:1103-4.
  8. Butowt R, Bilinska K. SARS-CoV-2: olfaction, brain infection, and the urgent need for clinical samples allowing earlier virus detection. ACS Chem Neurosci 2020;11:1200-3.
  9. Hummel T, Heilmann S, Huttenbriuk KB. Lipoic acid in the treatment of smell dysfunction following viral infection of the upper respiratory tract. Laryngoscope 2002;112:2076-80.
  10. Heilmann S, Huettenbrink KB, Hummel T. Local and systemic administration of corticosteroids in the treatment of olfactory loss. Am J Rhinol 2004;18:29-33.
  11. Addison AB, Wong B, Ahmed T, et al. Clinical Olfactory Working Group consensus statement on the treatment of post infectious olfactory dysfunction. J Allergy Clin Immunol 2021;147:1704-19.
  12. Hopkins C, Alanin M, Philpott C, et al. Management of new onset loss of sense of smell during the COVID-19 pandemic - BRS Consensus Guidelines. Clin Otolaryngol 2021;46:16-22.
  13. Huart C, Philpott CM, Altundag A, et al. Systemic corticoste